Skip to main content
Equibles

Baird Financial Group, Inc.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1648711 MILWAUKEE, WI
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,448,240
-$496,446 QoQ
Shares Held
38,898
-7.3% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Baird Financial Group, Inc. holds $226,318,173 across 30 Biotechnology names. TARS ranks #11 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 368,978 $105,147,660
2 REGN
Regeneron Pharmaceuticals, Inc.
 52,845 $32,950,970
3 INCY
Incyte Corp
 224,855 $25,489,561
4 EXEL
Exelixis, Inc.
 437,138 $23,784,676
5 INVA
Innoviva, Inc.
 274,391 $6,231,419
6 TWST
Twist Bioscience Corp
 49,862 $5,129,802
7 BBIO
BridgeBio Pharma, Inc.
 38,672 $2,880,290
8 ASND
Ascendis Pharma A/S
 10,735 $2,863,239

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,448,240 38,898
2026-03-31 $2,944,686 41,977
2025-12-31 $3,842,464 46,928
2025-09-30 $3,201,969 53,878
2025-06-30 $2,498,697 61,681
2025-03-31 $5,691,385 110,792
2024-12-31 $7,885,740 142,419
2024-09-30 $4,816,280 146,436
2024-06-30 $3,364,286 123,778
2024-03-31 $4,662,687 128,272